English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Progress in oncolytic viruses modified with nanomaterials for intravenous application Review article
2023
Authors:  Chen, Liting;  Ma, Zhijun;  Xu, Chen;  Xie, Youbang;  Ouyang, Defang; et al.
Favorite | TC[WOS]:6 TC[Scopus]:5  IF:5.6/5.9 | Submit date：2024/01/10
Oncolytic Virus  Nanomaterials  Drug Delivery  Tumor Treatment  Intravenous Application  
High-throughput membrane-anchored proteome screening reveals PIEZO1 as a promising antibody-drug target for human esophageal squamous cell carcinoma Journal article
Qin, Xun, Ni, Zhen, Jiang, Jianjun, Liu, Xiguang, Dong, Xiaoying, Li, Mei, Miao, Kai, Rao, Shuan, Zhang, Wenqing, Cai, Kaican. High-throughput membrane-anchored proteome screening reveals PIEZO1 as a promising antibody-drug target for human esophageal squamous cell carcinoma[J]. Cancer Medicine, 2022, 11(19), 3700-3713.
Authors:  Qin, Xun;  Ni, Zhen;  Jiang, Jianjun;  Liu, Xiguang;  Dong, Xiaoying; et al.
Favorite | TC[WOS]:7 TC[Scopus]:7  IF:2.9/3.9 | Submit date：2022/07/29
Antibody-drug Conjugate  Esophageal Squamous Cell Carcinoma  Piezo1  
Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas Journal article
Li, Ping, Chen, Fengyang, Zheng, Jingbin, Yang, Yang, Li, Yuan, Wang, Yifei, Chen, Xin*. Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas[J]. Cancer Biology and Medicine, 2021, 18(4), 1010-1020.
Authors:  Li, Ping;  Chen, Fengyang;  Zheng, Jingbin;  Yang, Yang;  Li, Yuan; et al.
Favorite | TC[WOS]:9 TC[Scopus]:8  IF:5.6/5.9 | Submit date：2021/12/08
Bleomycin  Cyclophosphamide  Tnfr2  Tregs  Tumor Necrosis Factor